Cardiac Regeneration: Stem Cells and Beyond
Authors: T. Moerkamp, A.; Goumans, Marie-Jose
Source: Current Medicinal Chemistry, Volume 19, Number 35, December 2012 , pp. 5993-6002(10)
Publisher: Bentham Science Publishers
Abstract:After myocardial infarction, the lost healthy myocardium is replaced by non-contractile scar tissue which may lead to the development of heart failure and death. There is no curative therapy for the irreversible myocardial cell loss. This review will give an overview of the current options to restore the contractile force of the heart: the different stem cell sources as therapeutic agents in cardiac repair as well as more novel approaches like the activation of endogenous cell populations, the use of paracrine factors and engineered heart tissue.
Document Type: Research Article
Publication date: December 1, 2012
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.